Petteway; Stephen Robert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Petteway; Stephen Robert.The latest application filed is for "nucleic acids encoding dp-178 and other viral fusion inhibitor peptides useful for treating aids".

Company Profile

0.12.2

Petteway; Stephen Robert - Cary NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Isolated peptides derived from human immunodeficiency virus types 1 and 2 containing fusion inhibitory domains Grant 7,794,725 - Barney , et al. September 14, 2	2010-09-14
Methods for inhibition of membrane-fusion-associated events, including Hepatitis B virus transmission Grant 7,514,397 - Barney , et al. April 7, 2	2009-04-07
Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids App 20070202127 - Bolognesi; Dani Paul ; et al.	2007-08-30
Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids Grant 7,122,190 - Bolognesi , et al. October 17, 2	2006-10-17
Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission Grant 6,951,717 - Barney , et al. October 4, 2	2005-10-04
Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids App 20040052820 - Bolognesi, Dani Paul ; et al.	2004-03-18
Methods for the inhibition of epstein-barr virus transmission employing anti-viral peptides capable of abrogating viral fusion and transmission Grant 6,518,013 - Barney , et al. February 11, 2	2003-02-11
Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission Grant 6,479,055 - Bolognesi , et al. November 12, 2	2002-11-12
Compositions for inhibition of membrane fusion-associated events, including human parainfluenza virus transmission Grant 6,333,395 - Barney , et al. December 25, 2	2001-12-25
Human respiratory syncytial virus peptides with antifusogenic and antiviral activities Grant 6,228,983 - Barney , et al. May 8, 2	2001-05-08
Isolated peptides derived from the Epstein-Barr virus containing fusion inhibitory domains Grant 6,093,794 - Barney , et al. July 25, 2	2000-07-25
Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission Grant 6,060,065 - Barney , et al. May 9, 2	2000-05-09
Simian immunodeficiency virus peptides with antifusogenic and antiviral activities Grant 6,017,536 - Barney , et al. January 25, 2	2000-01-25
Measles virus peptides with antifusogenic and antiviral activities Grant 6,013,263 - Barney , et al. January 11, 2	2000-01-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.